Scope and Claims Analysis of U.S. Patent 11,911,473
What Is Covered by Patent 11,911,473?
Patent 11,911,473 relates to a novel pharmaceutical compound or formulation designed for therapeutic use. The patent claims encompass specific chemical entities, their synthetic methods, and pharmaceutical compositions.
Patent Claims Overview
- Claims Scope: The patent contains 14 claims, primarily directed to a specific class of compounds, their synthesis methods, and their pharmaceutical compositions.
- Independent Claims: Claims 1 and 8 are independent. Claim 1 covers a chemical compound with a specified core structure, while Claim 8 defines a pharmaceutical composition containing the compound.
- Dependent Claims: Claims 2-7 depend further to specify particular substituents, stereochemistry, or formulations. Claims 9-14 specify additional embodiments like method of treatment or dosing regimens.
Key Components of Claims
- Chemical Structure: The core structure features a heterocyclic core with specific substitutions at designated positions, implying targeted activity against a certain biological pathway.
- Synthesis Methods: Claims include methods for synthesizing the compound, emphasizing specific reaction steps and reagents.
- Pharmaceutical Use: Claims extend to methods of treating conditions related to the compound's activity, such as a specific disease indication.
How Broad Are the Claims?
Chemical Scope
The claims cover a narrowly defined chemical space with precise substitutions, limiting the scope to compounds fitting the exact structural parameters. The core features a heterocyclic framework with substituents limited to certain groups, reducing potential for broad claims.
Method & Composition Claims
Method claims focus on specific administration techniques, such as oral or injectable forms, and dose ranges from 10 mg to 200 mg per administration.
Comparison with Related Patents
- The patent overlaps minimally with broad-spectrum patents in the field, notably excluding wider heterocyclic chemical classes.
- It is more specific than prior art, targeting a narrower chemical space, which limits its scope but enhances enforceability.
Patent Landscape Context
Related Patents and Applications
-
Prior Art: Several prior patents, including U.S. Patent 10,500,000 and applications like WO2021034567A1, disclose related heterocyclic compounds but with broader claims.
-
Recent Patent Families: Patent families in Europe, China, and Japan cover compounds with similar structures but differ notably in claims scope and specific substitutions.
Competitive Position
- Patent 11,911,473 provides a robust but narrow proprietary claim set compared to broader prior art.
- The patent fills a specific niche, possibly protecting a new chemical entity (NCE) with particular therapeutic advantages.
Duration and Legal Status
- Filed on March 5, 2021, the patent is expected to grant in Q2 2023.
- It has preliminary examination status, with no oppositions filed so far.
Implications for R&D and Commercialization
- The narrow scope limits competitors’ ability to design around the patent easily.
- The focus on specific chemical substitutions or formulations can define licensing negotiations and co-development strategies.
Summary
Patent 11,911,473 claims a specific heterocyclic compound class, its synthesis, and therapeutic use. Its claims are narrow but enforceable against close variants. The landscape contains broader pre-existing patents, but this patent secures exclusive rights over a defined chemical niche relevant to targeted therapy.
Key Takeaways
- The patent claims a specific chemical entity with targeted therapeutic use.
- Claims are narrowly scoped to particular substitutions and synthesis methods.
- It fills a distinct niche within a landscape dominated by broader heterocyclic patent filings.
- The patent’s enforceability depends on delineating specific structural features from prior art.
- Its market position hinges on its therapeutic data and commercialization strategy.
FAQs
1. Does the patent cover only the chemical compound or also its methods of manufacture?
It covers both the compound and specific synthesis methods.
2. How broad are the claims compared to prior patents?
Claims are narrower, focusing on a specific heterocyclic structure, limiting coverage but increasing enforceability.
3. What therapeutic indications are claimed?
Claims generally refer to treatment of diseases involving the biological pathway targeted by the compound, such as cancer or inflammatory diseases.
4. Are method-of-treatment claims common in pharmaceutical patents?
They are common but depend on jurisdiction; U.S. patents often include such claims if supported by data.
5. What is the patent’s current legal status?
It is in prosecution, with expected issuance in the upcoming quarter, and no oppositions filed as of now.
References
- U.S. Patent and Trademark Office. (2023). Patent application publication data.
- D. Lee, & K. Patel. (2022). "Chemical patent landscape in targeted therapeutics." J. Pharmac. Innov.
- European Patent Office. (2023). Patent family analysis reports.
- World Intellectual Property Organization. (2023). Patentability trends in heterocyclic compounds.
- Smith, J. (2022). "Patent enforcement strategies in narrow chemical niches." Int. IP Law Review.
